STAT

NOVEMBER 29, 2022

SAN FRANCISCO — A closely watched new treatment for Alzheimer’s disease held up to scrutiny in a detailed scientific presentation Tuesday, as its developers, partners Eisai and Biogen, begin the lengthy process of turning this medicine into what they hope could be a groundbreaking therapy.

143

143

STAT

DECEMBER 6, 2022

Two vastly different experiences — serving as a “guest coach” on the sidelines for a Division I football team and volunteering in a busy emergency department — showed me just how unequal and damaging the lack of care provided for women who are victims of domestic violence can be. Read the rest…

142

142

STAT

AUGUST 8, 2023

Novo Nordisk’s obesity drug Wegovy cut the risk of major heart complications by 20% in a closely watched trial, results that could streamline insurance coverage and spur even greater demand for the highly popular therapy.

Insurance Coverage 98

Insurance Coverage Insurance 98

STAT

JUNE 9, 2023

Leqembi was granted conditional approval in January based on preliminary evidence showing it could eliminate toxic brain plaques from people diagnosed with early-stage Alzheimer’s. Brain swelling and small brain bleeds were the most closely watched and concerning side effects attributed to Leqembi.

FDA 99

FDA 99

pharmaphorum

JUNE 8, 2022

Owners of an iPhone or Apple Watch have a new health feature, an app called Medications, that will help them manage and track their use of medicines. Another was a new feature for the Apple Watch , which has a built-in ECG that can already be used to identify signs of atrial fibrillation (AFib), a potentially serious heart condition.

Documentation 131

Documentation Labelling FDA 131

STAT

JUNE 5, 2023

In an important reminder that plugging digital tools into a clinical trial will not magically solve problems, Bellerophon Therapeutics announced Monday it would abandon a study of its treatment for pulmonary fibrosis after patients in a Phase 3 trial using a digital endpoint showed no improvement.

97

97

STAT

FEBRUARY 9, 2024

You could curl up in front of the telly to binge watch a series or two, or enjoy a moving picture show. Pharmalot with a rotation that will include this , this , this , this and this. And what about you? This remains a fine time to enjoy the great indoors. Or perhaps you could catch up on your own reading list. But be safe.

Vaccines 103

Vaccines 103

pharmaphorum

OCTOBER 25, 2021

Hard on the heels of some impressive clinical trial results, Luminopia has won FDA approval for its digital therapeutic (DTx) for amblyopia or lazy eye in children that is based on watching TV shows. Another digital approach to treating amblyopia is being tested by Amblyotech, which was acquired by Novartis last year.

FDA 111

FDA Hospitals 111

STAT

MARCH 15, 2024

Or if you prefer, you could curl up in front of the telly for a new round of binge-watching, or simply catch up on your reading. Final approval will be contingent on the results of an ongoing study designed to show the drug can improve long-term outcomes for patients. And what about you? Well, whatever you do, have a grand time.

90

90

STAT

JULY 20, 2023

Read the rest…

98

98

The Checkup by Singlecare

FEBRUARY 24, 2023

Maybe it was spending Valentine’s Day with your sweetheart or watching the Chiefs win the Super Bowl. When you go to the pharmacy, show your pharmacist the coupon. What was your favorite thing about February? Did you know that February is also American Heart Month? Here’s to saving!

Dosage 98

Dosage 98

STAT

OCTOBER 20, 2023

Or if the weather does not permit, you could curl up with a book or binge-watch on the telly. But Lilly contended the products actually contain impurities and testing showed one company is selling “nothing more than sugar alcohol.” This is a fine time for a drive in the country. Well, whatever you do, have a grand time.

105

105

STAT

DECEMBER 22, 2023

You could go out and about and sample some fun eateries or perhaps binge watch those moving picture shows you missed. The end-of-year holiday break is upon us, so this, of course, is an opportunity to connect with special folks or, if need be, find some needed alone time. Well, whatever you do, have a grand time. But be safe.

104

104

European Pharmaceutical Review

JANUARY 10, 2023

Clarivate Plc has released its Drugs to Watch 2023 report — among 70 of the drugs highlighted, including potential blockbuster drugs, the majority were revealed to be personalised medicines. Seven of the potential blockbuster Drugs to Watch in 2023 are: . Other potential blockbuster Drugs to Watch in 2023.

FDA 93

FDA 93

STAT

AUGUST 8, 2023

… Novo Nordisk’s obesity drug Wegovy cut the risk of major heart complications by 20% in a closely watched trial, results that could streamline insurance coverage and spur even greater demand for the highly popular therapy , STAT reports.

Insurance Coverage 96

Insurance Coverage Insurance 96

pharmaphorum

MARCH 25, 2022

At last year’s American Heart Association meeting, Google presented the results of a study involving 450,000 Fitbit users showing that the algorithm accurately identified undiagnosed AFib 98% of the time when combined with an ECG patch sent to those who received an alert from the wearable. AFib is common in the US, affecting around 12.1

FDA 122

FDA 122

STAT

JANUARY 20, 2023

This may be a fine time to indulge in a new round of binge-watching on the telly, or you could catch up on your reading. ” Lilly filed for accelerated approval based on a mid-stage study that showed the drug lowered levels of amyloid. And what about you? Continue to STAT+ to read the full story…

FDA 94

FDA 94

STAT

JULY 28, 2023

You could take in a moving picture show or head to your local temple of consumption. Whether the government agrees that adding an ingredient enabling infused drugs to be given by injection will allow them to be considered new medicines and significantly delay eligibility for price negotiations is being closely watched.

97

97

pharmaphorum

APRIL 27, 2021

Autism can be difficult to diagnose as there are no medical markers to show its presence – instead doctors look at the child’s developmental history and behaviour to make a diagnosis. The app could be used to screen young children with autism spectrum disorder based on their eye movements while watching videos, results showed.

FDA 105

FDA 105

The Checkup by Singlecare

JANUARY 10, 2024

Some research shows that berberine may help with weight loss , but data proving its effectiveness is limited—and some benefits are shown in animal research only. One study showed that subjects had a five-pound weight loss over the course of 12 weeks. “The Additionally, if you have diabetes , you must watch your blood sugar closely.

Dosage 105

Dosage Compounding Insurance FDA 105

pharmaphorum

SEPTEMBER 17, 2021

The DTx – called Luminopia One – treats amblyopia by getting people with the condition to watch specially modified TV shows and movies using a virtual reality headset designed to promote use of the weaker eye. ” Another digital approach to treating amblyopia is being tested by Amblyotech, which was acquired by Novartis last year.

FDA 72

FDA 72

Pharma Mirror

MAY 6, 2021

Are you catching yourself turning the volume up when listening to the radio or watching a TV show? Have thought about what might be the reason behind that, or have you just assumed that it is perfectly normal and that there is absolutely no reason to worry about anything? If it’s the latter, then I suggest you think twice.

52

52

pharmaphorum

OCTOBER 27, 2022

You can also watch the entire podcast as a video below: The post Live from Frontiers Health 2022 – the pharmaphorum podcast appeared first on. In this podcast, they discuss digital therapeutics and the new phase these seem to have moved into, focused on scale and adoption.

52

52

STAT

JUNE 9, 2023

Or if you prefer remaining indoors, you can catch up on your reading or binge-watch something on the telly. Leqembi was granted conditional approval in January based on preliminary evidence showing it could eliminate toxic brain plaques from people diagnosed with early-stage Alzheimer’s. Well, whatever you do, have a grand time.

FDA 92

FDA Documentation Vaccines 92

European Pharmaceutical Review

MAY 31, 2023

Yet the balance sheets of the pharmaceutical manufacturers included in the report showed limited evidence of this. Inventories grew to a combined total of $150bn in 2022, the analysis showed. EMA guidance aims to prevent medicine shortages However, the balance sheets of pharmaceutical manufacturers show limited evidence of shortages.

Vaccines 103

Vaccines 103

IDStewardship

OCTOBER 18, 2023

Over the last few years, among the amusement of watching gators walk across crosswalks, and exploring UF campus festivities, I have witnessed the hardships and not-so-fun aspects of pharmacy school overshadow the fantastic opportunities we have as students too many times.

182

182

pharmaphorum

MARCH 23, 2022

The full data isn’t being made available yet, but will be watched keenly to see how it stacks up with etrasimod’s main rival, Bristol-Myers Squibb’s S1P drug Zeposia (ozanimod), which was approved for ulcerative colitis last year and is also used to treat relapsing multiple sclerosis.

98

98

pharmaphorum

DECEMBER 15, 2022

Boehringer did not carry out a dedicated clinical trial to show the benefit of Ofev in this less severely affected population, but provided subgroup analyses from two earlier studies – INPULSIS and TOMORROW – plus open-label extensions.

Labelling 105

Labelling Hospitals 105

NF2 BioSolutions

JULY 25, 2023

Also if you are interested in watching a video summary of the paper then just follow the full open access paper link , scroll down the page to find the video abstract ! Watch this space and please join in helping us all connect and share with one another! We have a new NF2 BioSolutions UK funded research paper out!

Immunization 98

Immunization Communication 98

pharmaphorum

APRIL 1, 2022

And with the availability of two versions—a branded and unbranded version—the industry will watch closely how both products compete in the commercial market versus Medicare Part D plans, and whether any other insurers adopt it to their formularies. So, it will be interesting to watch how this continues to play out.

FDA 59

FDA Insurance Pharmaceutical Companies Pharmaceutical Companies 59

Hospital Pharmacy Europe

OCTOBER 12, 2023

Jonathan Knight, CEO and co-founder of Tefogo, the company behind the passport software, added: ‘It’s been incredible to watch more than 100 pharmacists come together as part of BOPA to create and agree a unified approach to SACT verification training.

Chemotherapy 52

Chemotherapy Hospitals 52

The Checkup by Singlecare

FEBRUARY 8, 2023

Here are 11 signs to watch for. Swelling, redness, or heat Research shows that infection and tissue injury are the leading causes of inflammation. Additionally, research shows that an inflammatory diet is linked with an increased risk of dementia. Research shows that exercise has an anti-inflammatory response. Trinh says.

Immunization 105

Immunization 105

The Checkup by Singlecare

AUGUST 11, 2023

Alcohol and ibuprofen interactions to watch for If you combine alcohol and ibuprofen, you should keep an eye out for potential signs of complications—especially if you are at high risk.

Mayo Clinic 97

Mayo Clinic Compounding Labelling 97

Board Vitals - Pharmacist

AUGUST 31, 2022

While the players prepare for the game on the field, another team is watching for something more important off the field. Four specially trained “spotters” watch every game from the stadium press box and pull players who may have been involved in concussion-causing collisions. Shows mood, behavior, or personality changes.

97

97

pharmaphorum

MARCH 19, 2021

Over 1000 people tuned in online to watch the virtual awards ceremony which was hosted by PM Society Chairs Caroline Benson and Colin Williams and head judge Sarah Sowerby from Wordbird. The ceremony included an online magic show by magician Matt Parro and interviews with Rory Sutherland, vice chairman, Ogilvy and Ben Osborn, UK MD, Pfizer.

Communication 52

Communication 52

pharmaphorum

OCTOBER 31, 2021

Presbyopia is caused by a stiffening in the lens of the eye that develops in people after the age of 40, and affects an estimated 128 million people in the US, and seems to be becoming more of a problem – perhaps because we spend more time using devices up close like phones and smart watches. Brimochol is in phase 2 testing.

FDA 105

FDA 105

pharmaphorum

NOVEMBER 11, 2021

According to the investigators, the data generated by MSCopilot correlated closely with both the MSFC and EDSS scores, showing that the SaMD was able to provide an accurate picture of MS status and evolution for patients and clinicians.

59

59